No title
The quantity of biomarkers, which are proteins in this case, in ovarian cancer (OC) tumor and immune tissue regions of interest (ROIs) were measured with the new technology Digital Spatial Profiler (DSP). These measurements were used to construct regression models on the biomarkers to predict for two clinical parameters; tumor type (”Type 1” vs ”Type 2”) and the immune infiltration type (”Cavities
